REGENTS OF THE UNIVERSITY OF MICHIGAN THE has a total of 22 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are NAT INSTITUTE OF IMMUNOLOGY, THE CHEMO-SERO-THERAPEUTIC RES INST and HEPACORE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 22 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Materials and metallurgy | |
#6 | Environmental technology | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Townsend Leroy B | 3 |
#2 | Nabel Gary J | 3 |
#3 | June Carl H | 3 |
#4 | Thompson Craig B | 3 |
#5 | Drach John C | 2 |
#6 | Nabel Elizabeth G | 2 |
#7 | Fisher Gary J | 1 |
#8 | Adamson Belinda | 1 |
#9 | Bierer Donald E | 1 |
#10 | Yang Victor C | 1 |
Publication | Filing date | Title |
---|---|---|
AU4515001A | Compositions and methods for locally treating inflammatory diseases | |
AU5167200A | Cell-coated supports | |
AU3214797A | Engineering oral tissues | |
AU5636496A | Improved methods for transfecting t cells | |
AU4602396A | Dna encoding a 20 kd cdk6 inhibiting protein | |
AU3692895A | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring | |
AU7107794A | Cd28 pathway immunosuppression | |
AU6829994A | Gene transfer into pancreatic and biliary epithelial cells |